Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PlasmaCord intravenous infusion in adults with severe COVID-19 requiring ICU transfer
RBR-4pfygrPhase 2Not yet recruiting
- Sponsor
- Cryopraxis
- Start
- Jul 2020
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of plasmacord in coronavirus disease 2019 (COVID-19), sponsored by Cryopraxis. Primary endpoints: Safety and Tolerability. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
plasmacord
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-4pfygr.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4pfygr.